Regen BioPharma, Inc. (RGBP)
Develops cell therapies and drugs that boost immune cells to fight cancer and autoimmune diseases.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-99.8%
The outlook
RGBP is trading near its 52-week low at $0.0001, well below both its 50- and 200-day moving averages. Analyst coverage appears minimal or absent. The stock shows a bearish technical picture with little upward momentum in recent months.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$51,195
52-wk high
$0.07
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—